Lead Recycler's First Public Print — Growth Momentum & Margin Stability in Focus
Ardee Industries reports its inaugural quarter as a public company. Fresh off a 133x-oversubscribed IPO and 35% listing-day pop, investors will scrutinize capacity utilization, margin hold amid leverage, and the pace of battery-scrap collection driving Q1 volumes.
Ardee Industries Limited, India's leading secondary metals recycler and lead-acid battery processor, reports its first quarterly result as a public company. The August 12 listing (133.42x subscription, listing price ₹72 vs. issue ₹53) underscores investor conviction in the secular battery-recycling and EV-driven lead-demand tailwinds. Q1 FY27 (Apr–Jun 2026) is the first full quarter reflecting the company's May 2026 capacity expansion to 156,950 MTPA—a 45%+ increase from prior scale—and will set the tone for street expectations on execution risk, working-capital efficiency, and the pace of revenue accretion into FY27.
On-Plan Expectations
~₹280–320 Cr
Q1 FY26 baseline (~₹180 Cr run-rate pre-expansion); FY26 saw 57% YoY growth. Q1 FY27 reflects partial-quarter benefit of expanded capacity (May onwards) plus seasonally normal demand.
~12–14%
FY26 reported 12.6% margin. Margin profile will hinge on lead-price realization, scrap-collection rates, and leverage of 45% higher capacity. Watch for gross margin vs. fixed-cost absorption.
~44% of revenue
FY26 split: 44% battery (end-of-life automotive & industrial), 43% metal (lead alloys & pure lead). Q1 pace will reveal if expansion capacity is feeding both segments equally.
~70–85%
New 156,950 MTPA capacity from May 2026. Q1 utilization critical signal: strong scrap supply chains and battery collection momentum, or ramp friction?
What a strong print looks like: Revenue north of ₹300 Cr with EBITDA margin of 13%+ (showing efficient absorption of new capacity), capacity utilization >75%, and management guidance maintaining FY27 full-year run-rate of ₹1,400 Cr+. Scrap-battery collection volumes beat-in relative to prior-year, signalling the company's sourcing moat is intact post-IPO. What a weak print looks like: Revenue below ₹280 Cr (suggesting slow ramp or demand softness), margin slip below 12% (pressure from underutilized assets or lead-price dips), or management commentary signalling tighter raw-material availability. Any guidance cut would concern an IPO-flush market.
Is the Company On Track?
Ardee's trajectory is strong but unproven at scale. FY24–FY26 showed 58.8% revenue CAGR and 207.5% PAT CAGR—exceptional by any metric. However, the May 2026 capacity doubling is the company's largest organic investment; Q1 FY27 will be the first read on whether the execution, supply chains, and sales infrastructure can sustain that growth velocity. The IPO capital raise (₹425 Cr gross) was sized to fund growth CapEx and reduce leverage; management's ability to keep net debt/EBITDA in the 1.5–2.0x band (vs. prior leverage) will be a Street proxy for financial discipline. No analyst consensus is yet published (newly listed), so the Board's commentary on FY27 guidance will be the first consensus builder.
Street View (Thin Coverage, High Conviction)
Since Last Quarter — Recent Events
1 · IPO Listing (Aug 12, 2026)
Company listed at ₹72 per share, 35% premium to issue price of ₹53. IPO raised ₹425.87 Cr (₹320 Cr fresh issue, ₹105.87 Cr offer-for-sale). Oversubscription of 133.42x indicates strong institutional and retail demand. Significance: capital now in hand for growth; leverage reduction underway.
2 · Insider Trading Window Closure (Aug 12, 2026)
Trading window for designated persons and immediate relatives closed from August 12 until 48 hours after result announcement (expected Aug 27). Significance: routine precaution; no material insider activity flagged.
3 · Bulk / Block Deals (Aug 12–14, 2026)
Post-listing bulk activity: VINOD MANJIBHAI CHAUHAN (likely promoter) executed paired bulk sales and buys (Aug 14, 16,64,661 shares sold @ ₹59.35; 3,59,661 shares bought @ ₹59.47). Also activity from NK SECURITIES RESEARCH, TWO ROADS TRADING, MICROCURVES TRADING, and others. Significance: Post-IPO founder rebalancing; no distress signal, but watch for promoter pledge if leverage was used for IPO expense.
4 · Capacity Expansion Completion (May 2026)
Installed recycling capacity scaled from ~108k MTPA to 156,950 MTPA (45% increase) as of May 2026. This is Ardee's largest organic CapEx to date. Significance: Q1 FY27 will be the first full quarter with expanded capacity; ramp-up and utilization rates are critical to monitor.
All recent filings are operationally routine. No material regulatory warnings, compliance issues, or pledges disclosed. The closure of insider trading window is standard pre-result practice.
What to Watch on Aug 25
1 · Revenue Growth & Capacity Ramp
Does Q1 revenue track the on-plan ~₹300+ Cr run-rate? Is capacity utilization >75%? Any commentary on scrap-collection pipelines and the sourcing moat post-IPO? A miss here sets a cautious tone for FY27 guidance.
2 · Margin Stability Amid Expansion
Can EBITDA margin hold 12%+ as the company absorbs 45% higher fixed-asset base? Any comment on lead-price hedging or raw-material cost trends? This is where IPO investors will test financial discipline vs. growth ambition.
3 · FY27 Guidance & Capital Allocation
Will management reiterate a ₹1,400+ Cr FY27 revenue target? Any reduction in CapEx guidance following the May 2026 expansion? Debt-reduction pace (use of IPO proceeds) will signal financial policy.
4 · Sector Tailwinds & Risk Headwinds
Any update on battery-recycling policy or EV adoption in India? Conversely, any color on lead-price volatility or competitive pressure from new entrants? These shape the multi-quarter demand outlook.
5 · Working Capital & Cash Flow
With expanded capacity, working-capital intensity (inventory, receivables) may shift. Is the company generating strong operating cash flow to service debt and fund future CapEx without fresh dilution?
Ardee Industries' Q1 FY27 result is a litmus test for the company's ability to scale profitably after its landmark IPO. The 45% capacity expansion (completed May 2026) is the central inflection; strong utilization and margin hold will signal the expansion thesis is sound. Investors who piled into the 133x-oversubscribed IPO are pricing in sustained 20%+ revenue growth and stable EBITDA margins—a bar that management must clear on August 25. A weak ramp or margin slip will pressure the stock and reset Street expectations downward.
Ardee's debut quarter: revenue +35% YoY, EBITDA margin cools to ~10% vs 12-14% guided
PAT +5.99% YoY · revenue +35.19% · margins compressing · miss vs street
₹338.81 Cr
+35.19% YoY
₹19.9 Cr
+5.99% YoY
5.87%
₹0.78
Ardee Industries Limited (standalone; no consolidated statement filed) reported revenue from operations of ₹338.81 Cr for Q1 FY27 (quarter ended June 30, 2026), up 35.2% year-on-year from ₹250.62 Cr in Q1 FY26, though down 4.3% sequentially from ₹353.97 Cr in Q4 FY26. Net profit came in at ₹19.90 Cr, up just 6.0% YoY (₹18.78 Cr) and down 16.2% QoQ (₹23.74 Cr) — profit growth trailed revenue growth by a wide margin, the defining feature of the quarter. EPS was ₹0.78 (basic and diluted), against a post-bonus-adjusted ₹0.74 a year earlier. No exceptional or one-off items appear in either the current or comparative periods, so the slowdown in profit growth is operating in nature.
Q1 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The margin compression traces almost entirely to a swing in inventory movement rather than input-cost inflation: cost of materials consumed actually fell to 77.8% of revenue (₹263.70 Cr) from 81.3% a year ago, and finance costs eased to 1.3% of revenue (₹4.33 Cr) from 2.3% (₹5.63 Cr) — both improved YoY. But the "(increase)/decrease in inventories" line flipped from a ₹9.30 Cr benefit in Q1 FY26 (inventory build) to a ₹14.24 Cr cost in Q1 FY27 (inventory drawdown), a roughly 790-basis-point swing that alone explains most of the gap between 35% revenue growth and 6% profit growth. Employee costs rose to ₹8.11 Cr from ₹6.01 Cr as the cost base scaled with the business. Net result: EBITDA margin (PBT + depreciation + finance costs, over revenue) fell to ~9.96% from ~13.52% YoY and ~11.22% QoQ.
This is Ardee's first result as a listed company: the IPO (133.4x oversubscribed, fresh issue of 6.04 Cr shares at ₹53) listed on August 12, 2026 — after this quarter closed — with a 35% listing-day pop to ₹72, so the ~₹320 Cr of fresh-issue proceeds and any further deleveraging are not yet reflected in this quarter's numbers. Against our pre-result preview (revenue ₹280-320 Cr, EBITDA margin 12-14%), the quarter beats on revenue (₹338.81 Cr) but misses the margin band by roughly 200-400 bps at ~9.96% — the exact risk ("margin hold amid leverage") the preview flagged as the key watch item, even though the miss traces to inventory movement rather than leverage or input costs. No formal analyst consensus exists yet for this debut print; the only estimate sourced (SPTulsian) pegs FY27E EPS near ₹4.5, an annual figure not directly comparable to this quarter. Management has issued no formal guidance on record and no separate press release or MD&A commentary accompanied this filing beyond the statutory notes; the company also discloses a single reportable operating segment under Ind AS 108, so the battery-scrap mix (~44% expected per our preview) cannot be verified from these numbers.
W1
EBITDA margin trajectory back toward the 12-14% band flagged pre-result — was ~9.96% this quarter, down from ~13.52% a year ago
W2
Deployment of the ~₹320 Cr fresh-issue IPO proceeds (raised Aug 12, 2026) toward debt reduction — finance costs were ₹4.33 Cr this quarter
W3
Capacity expansion completed May 2026 ramping toward the 70-85% utilization range flagged pre-result — no utilization figure disclosed yet
Standalone only — no consolidated statement filed. Figures sourced from INR Millions table, converted to Crore. Unaudited, subject to limited review; comparative Q1 FY26 figures were neither audited nor reviewed per auditor's report para 5. IPO completed Aug 12, 2026 (after quarter-end) — proceeds not reflected in this quarter's balance sheet. EPS restated for July 2025 bonus issue (15:1).
₹338 Crore Growth, Profit Quality Squeezed
Ardee's 35% revenue growth masks a sharper message: margin compression has swallowed the operating leverage, and management's conservative FY27 guidance signals conviction that headwinds will persist. The market's own verdict—sell on the pop, fade the relief—reads the same.
₹338.8 Cr
+35% YoY vs ₹250.6 Cr
₹19.9 Cr
+6% YoY; only 5.9% margin
10%
Down 260 bps from 12.6% FY26
65%
Target 70-75% by FY28
The headline reads as a blowout: 35% revenue growth in a post-IPO quarter. But look one line deeper. Ardee's profit grew 6% — a gap of 29 percentage points between revenue and earnings. This is the real story of Q1 FY27. The company scaled top-line sharply, but margin compression has consumed the leverage. And management's decision to hold near-conservative FY27 guidance (10–20% volume growth) despite 51% capacity added and a historical 58.8% CAGR tells you this isn't transient — it's structural.
Where the margin went
EBITDA fell to ₹33.8 Cr in Q1 from ₹33.1 Cr in Q1 FY26 — flat year-on-year despite 35% revenue growth. The culprit: raw material cost inflation (domestic scrap sourcing has become more expensive as import disruptions push demand domestic), petroleum and freight cost spikes from geopolitical upheaval, and capacity utilization at only 65% (versus optimum 70–75%). Gross profit per ton fell ₹3,500 (from ₹38,000 to ₹34,500 quarter-on-quarter), and EBITDA per ton at ₹19,000 shows no real improvement from prior periods.
35.2% YoY revenue growth
Supported₹338.8 Cr vs ₹250.6 Cr Q1 FY26 = 35.2%
Capacity expanded 50.9%, effective May 29
Supported1,56,950 MTPA vs prior 1,04,025 = 50.9% confirmed
EBITDA margin 10% in Q1 FY27
Supported₹33.8 Cr ÷ ₹338.8 Cr = 9.97%, rounds to 10%
Export revenue grown to ₹465 Cr FY26 from ₹81.6 Cr FY24
Supported471% growth stated; Q1 FY27 exports 38.7% of revenue = ₹131 Cr run-rate
Margin pressure from raw material and petroleum inflation
SupportedGross profit per ton fell ₹3,500 Q4→Q1; EBITDA per ton ₹19,000 vs ₹20,000+ prior
Volume decline Q4→Q1 due to geopolitical and procurement disruptions
SupportedQ1 volume 17,645 MT at 65% utilization; management cited war impact, import blockages
What changed on this call
This is Ardee's first earnings call post-IPO, so there is no prior guidance to miss against. But the call itself introduced several material shifts in market expectations. Margin guidance was reset: FY26 EBITDA margin was 12.6%, but the company guided ₹10% for FY27 — acknowledging that geopolitical cost inflation is not transient. Volume growth was dampened: with a 58.8% revenue CAGR over FY24–FY26 and 51% capacity just added, analysts pushed hard on why the company was guiding only 10–20% volume growth for FY27. Management held firm, citing Middle East blockages and procurement cost challenges, willing to 'overperform' but not to over-assert. Capacity ramp timeline was extended: the company guided that optimum 70–75% utilization would not be hit until FY28, not FY27 — a silent admission that the new capacity will take longer to digest than the tape expected. And exports were reaffirmed as a growth vector: Q1 exports were 38.7% of revenue (₹131 Cr), and the LME registration and MCX listing announced in this period are new credentials for international customer acquisition.
The bull-bear ledger
Long-term structural tailwind: circular economy, lead-acid battery demand (autos, backup power, renewable storage) expected to grow for a decade+
Export franchise deepening post-LME listing; international OEM inquiries flowing; 38.7% of Q1 revenue now export vs. ₹81.6 Cr (FY24) baseline
Customer concentration improving: largest customer down from 70% to ~40%; top 5 customers represent the max viable business (industry structural)
Strong historical execution: FY24–FY26 revenue CAGR 58.8%, PAT CAGR ~95%, margins expanded from 6.1% to 12.6%
EBITDA margin compression is real and not transient: 260 bps down to 10%, with FY27 guidance still at ~10% (no recovery assumed)
Profit quality weak: PAT grew only 6% despite 35% revenue growth, showing operating leverage loss
Capacity utilization delayed to FY28: 65% current vs. 70–75% target, implying near-term fixed-cost deleverage
Geopolitical disruption is an unquantified tail risk: Middle East blockages, import cost inflation, freight spikes — no visibility to resolution
Procurement cost inflation (domestic scrap higher than imports) — diversification into domestic and new geographies is work-in-progress, not complete
Risks, ranked by how much they should concern a holder
Geopolitical supply-chain disruption persists beyond FY27
HighMiddle East blockages and import cost inflation are depressing volumes and margins. If this extends into FY28, capacity utilization stays below optimum, fixed costs deleverage, and margin recovery stalls. Management offers no timeline to resolution, only 'caution.'
Margin recovery fails to materialize as commodity/freight costs stay elevated
HighThe company is guiding 10% EBITDA margin for FY27, implying no recovery from Q1's 260-bps compression even if volumes ramp. If input costs don't normalize, margin stays at 10% or worse, limiting earnings growth to volume-only (10–20%) for years.
Capacity utilization stays below 70% through FY27
Medium₹15 Cr capex was deployed for 52,925 MTPA of new capacity, but at 65% utilization, fixed costs spread over lower volume. Delayed ramp to FY28 means missed contribution and lower ROCE on capital deployed. If geopolitical drags on, utilization could stay at or below 65%.
Customer concentration risk despite improvement
MediumLargest customer is ~40% of business (down from 70%), but top 5 are structured to be ~100%. Loss of a large OEM (e.g., a battery manufacturer scaling in-house recycling) would hurt. Export growth to international OEMs is one hedge, but still nascent.
Domestic scrap sourcing diversification stalls; import costs remain sticky
MediumManagement acknowledged domestic scrap is more expensive (higher prices, GST complexity, unorganized-sector friction) than imports. If import normalization is delayed and domestic sourcing doesn't scale, procurement cost stays elevated, margins stay compressed.
Lead-acid battery market growth slower than circular economy thesis assumes
LowLong-term case rests on structural lead-acid demand (autos, backup power, renewable storage). If EV adoption accelerates faster than backup-power expansion, or if lead-acid is substituted by newer battery chemistries, addressable market growth slows. No concrete evidence yet, but a multi-year tail risk.
How the street is reading this
Price action: Ardee's result was announced at a pre-close price of ₹56.99. On day 1, the stock sold off 1.88% (to ₹55.93), a negative reaction that likely reflects margin compression and volume concerns being visible on the print. On day 3, the stock rallied 7.32% (to ₹60.07), possibly on relief from the earnings call (management provided clarity on margins being structural, not transient, and on geopolitical as the culprit — at least investors had an explanation). But by day 5, the rally had faded to a net loss of 1.39% (to ₹59.23). This fade is telling: the relief didn't stick. The market sold the pop, suggesting conviction on the downside thesis (margin recovery uncertain, capacity ramp delayed) outweighed the structural tailwind story.
Bulk and block activity: In the six weeks surrounding the result (mid-August), several institutional entities accumulated shares at ₹67–₹70 range (NK Securities, Two Roads Trading, GRT Strategic Ventures, Microcurves Trading), but with offsetting selling by the same firms — algorithmic profit-taking, not conviction buying. Vinod Manjibhai Chauhan (promoter-linked based on name match) also transacted bulk shares at ₹59.35 and ₹59.47, buying and selling in close proximity — a churn that signals no strong directional conviction from insiders either. The net message from order flow: institutional nibbling on weakness, but no one is doubling down, and insiders are flat-handed.
The debate
What to watch next
1 · H2 FY27 volume and margin recovery
Management signalled 'more confidence' in H2 amid supply-chain normalization hopes. If Q2–Q3 volumes ramp to 85,000+ MT (vs. 17,645 MT in Q1) and margins stabilize above 10%, that's evidence the geopolitical tail is lifting. If H2 volumes stay flat or H2 margins compress further, the guidance loses credibility.
2 · Capacity utilization progress toward 70%+
Q1 was 65%. If H2 sees utilization climb toward 70–72%, the company is on track for the FY28 70–75% target and fixed-cost deleverage will ease. If H2 stays at or below 65%, it signals demand is more constrained than long-term structural tailwinds suggest, and capital efficiency becomes a concern.
3 · Domestic scrap sourcing diversification progress
Management said it 'started participating in corporate auctions and direct buys' but acknowledged GST and unorganized-sector friction make domestic sourcing more expensive than imports. If Q2 results show that import normalization has eased (freight costs down, blockages cleared), the company may ease off domestic diversification. If not, management will need to show concrete sourcing wins and cost-mitigation progress to justify the long-term thesis.
The number to track from here
This is steady execution on a long-term thesis, not a step-change. Ardee's Q1 reported 35% revenue growth, but the real metric — profit quality and margin recovery — is where the debate lives. Track EBITDA margin and capacity utilization quarter-on-quarter. If FY27 margins stay at 10% and utilization stalls below 70%, the company is capital-constrained and geopolitical headwinds are more durable than the structural tailwind narrative suggests. If H2 FY27 shows margins at 11%+ and utilization at 70%+, the path to 12%+ margins and 20%+ EBITDA growth in FY28 becomes credible, and the hold becomes an accumulate. Until then, the faded relief rally and insider flatness are the honest read: the market wants to see proof before re-rating the stock.
Growth intact, margins squeezed; capacity ramp delayed to FY28
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
First earnings call post-IPO; FY24-FY26 track record strong (58.8% revenue CAGR, PAT CAGR ~95%); no prior numeric guidance to miss against.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong 35% YoY revenue growth and structural tailwinds (circular economy, LME listing, 51% capacity expansion) offset by 260-bps margin compression, conservative FY27 guidance (10-20% volume growth, ~10% EBITDA margin), and delayed capacity utilization to FY28. Near-term headwinds (geopolitical disruption, procurement challenges, commodity exposure) cap upside; long-term positioning remains sound.
₹338.8 Cr
Revenue · +35.2% YoY₹19.9 Cr
Reported PAT · +6% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
EBITDA margin 10% in Q1 FY27
MET₹33.8 Cr EBITDA ÷ ₹338.8 Cr revenue = 9.97% (round 10%)
35.2% YoY revenue growth
MET₹338.8 Cr vs ₹250.6 Cr Q1 FY26 = 35.2% growth
Capacity expansion 50.9% effective May 29, 2026
MET1,56,950 MTPA vs prior 1,04,025 MTPA = 50.9% increase confirmed
Export revenue grew to ₹465 Cr in FY26 from ₹81.6 Cr FY24
MET471% growth stated; Q1 FY27 exports 38.7% of ₹338.8 = ₹131 Cr run-rate
Volume decline Q4→Q1 due to geopolitical and procurement disruptions
METQ1 volume 17,645 MT at 65% utilization; management cited war impact, import blockages
Margin pressure from raw material and petroleum cost inflation
METGross profit per ton fell ₹38,000 (Q4) → ₹34,500 (Q1); EBITDA per ton ₹19,000 vs prior ₹20,000+
Earnings quality
What changed since the last call
Margin outlook downgraded
DowngradeFY26 EBITDA margin 12.6% → Q1 FY27 10%; FY27E ~10% (vs 12%+ prior expectations). Driven by ₹4,500/ton gross profit decline and petroleum/raw material inflation.
Volume growth guidance conservative
NewFY27 guidance 10-20% (vs historical 58.8% CAGR FY24-26). Management citing geopolitical disruption, procurement challenges, not market demand weakness.
Capacity utilization timeline extended
New70-75% optimum pushed to FY28 (not FY27) despite 51% capacity addition in May. Current 65% utilization held due to market caution.
Export growth reaffirmed
MaintainedExports grew to ₹465 Cr FY26 (up from ₹81.6 Cr FY24); Q1 FY27 exports 38.7% of revenue. LME listing (announced this period) new credential.
The Q&A
Analysts pushed back on conservative 10-20% volume guidance given strong historical growth and new capacity, questioning if management was under-guiding. Management held firm, citing sustained geopolitical uncertainty and Middle East trade blockages; willing to 'overperform' but chose caution over optimism.
Volume decline Q4→Q1 — Aniket Madhwani, Steptrade Capital
AnsweredWar-driven import disruptions and procurement challenges forced strategic conservative positioning; capacity still ramping, utilization 65% vs 70-75% optimal.
Customer concentration — Vivek Jhala, Jhala Family Office
AnsweredConcentration already fell 70% → 40%; will continue declining as company grows. Top 5 customers will remain ~max business; structure inherent to the industry.
Working capital deployment — Vivek Jhala, Jhala Family Office
AnsweredMostly for scrap sourcing from new geographies and developing export origins (higher credit). Sustainable WC cycle 90-100 days; gross requirement ₹400+ Cr FY27.
ROCE dilution from new equity — Vivek Jhala, Jhala Family Office
PartialHistorically low capex = high ROCE; new equity will dilute ratios. Target to maintain 20%+ range long-term despite balance-sheet expansion.
Margin outlook — Nishita, Sapphire Capital
AnsweredGeopolitical scenario ongoing; safer to guide ~10% for full FY27 rather than 13%.
Hedging effectiveness — Anirudh Sharma, Ekaant Investments
AnsweredWorks efficiently; daily audit system, no positions left unhedged, zero margin impact from unhedged commodity exposure.
Procurement cost and volume guidance credibility — Dhairya Trivedi, DJT Corporation
AnsweredBeing conservative; willing to overperform. Whole 20% is volume-only (no metal price growth); supply-chain caution. Targeting ~85,000 MT FY27 vs 70,600 MT Q1.
Lithium-ion battery recycling — Aniket Madhwani, Steptrade Capital
AnsweredNothing concrete; evaluating multiple opportunities. Lithium is one but no direct entry planned now.
Domestic procurement diversification — Arvind Arora, A Square Capital
PartialAlready started participating in corporate auctions and direct buys. Challenges include higher domestic prices, GST complexity, unorganized sector. Working on it.
Lead alloys growth — Ankur Gulati, Genuity Capital
AnsweredRunning ~30-35% growth. OEM approvals slow ramp; gradual scaling. Capacity reallocation between pure lead and alloys ongoing.
Guidance
FY27 +10% to +20% volume growth
MediumVolume-driven only; no metal price appreciation. FY26 baseline ₹1,167.7 Cr implies ₹1,285-1,401 Cr FY27. Targeting ~85,000 MT FY27 (from 70,600 MT Q1 = ~282K MT FY26 annualized base).
EBITDA margin ~10% FY27
MediumDown from 12.6% FY26. Geopolitical impact (freight, import costs) expected to persist; room for recovery if macro stabilizes but not in base case.
No major capex FY27
High₹15 Cr brownfield done; new land (5.56 acres) for future phases, not immediate deployment. Exploring opportunities on new land but no concrete timelines.
Risks the call surfaced
Geopolitical supply-chain
HighWar-driven Middle East blockages and trade cost inflation constraining volumes and margins. Management cited as primary reason for conservative FY27 guidance despite 35% YoY growth.
Customer concentration
MediumLargest customer reduced from 70% to ~40%, top 5 always ~max business. Industry structure (few large OEM relationships) inherent but concentration remains.
Commodity price exposure
MediumBusiness inherently commodity-linked (lead spot prices). Back-to-back hedging mechanism works but basis risk, timing gaps, or unhedged pockets could impact profitability.
Capacity utilization ramp delay
MediumDespite ₹1.57L MTPA installed capacity (May 2026), only 65% utilized in Q1; management expects 70-75% optimum by FY28, not FY27. Implies near-term margin pressure from fixed-cost deleverage.
Margin recovery uncertainty
MediumQ1 EBITDA margin 10% vs 12.6% FY26. FY27 guidance still ~10%; no recovery built in unless geopolitical situation improves. Raw material (domestic) and petroleum cost inflation blamed.
Management
Score 7/10. Clear, transparent on challenges. Candid about geopolitical headwinds, margin pressure, capacity ramp delays. Did not spin or over-promise; chose conservative guidance despite strong track record. Strong FY24-26 track record: 58.8% revenue CAGR, PAT grew 9 Cr → 84.7 Cr. Q1 FY27 confirmed ₹338.8 Cr revenue and ₹19.9 Cr PAT aligned with actual. On guidance: capacity expansion delivered on-budget (₹15 Cr) in May.
1 · H2 FY27
Seasonal upside; management 'more confident' on H2 amid supply-chain normalization hopes
2 · FY28
Capacity utilization ramps to optimum 70-75%; margin recovery if commodity costs stabilize
3 · 2026-27
Domestic scrap sourcing diversification to reduce import dependency and freight exposure
Near-term headwinds (geopolitical disruption, procurement challenges, commodity exposure) cap upside; long-term positioning remains sound.